These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 28511053

  • 1. Opioid analgesics and heroin: Examining drug misuse trends among a sample of drug treatment clients in Kentucky.
    Victor GA, Walker R, Cole J, Logan TK.
    Int J Drug Policy; 2017 Aug; 46():1-6. PubMed ID: 28511053
    [Abstract] [Full Text] [Related]

  • 2. Opioid Misuse Trends in Treatment Seeking Populations: Revised Prescription Opioid Policy and Temporally Corresponding Changes.
    Hoffman LA, Lewis B, Nixon SJ.
    Subst Use Misuse; 2017 Dec 06; 52(14):1850-1858. PubMed ID: 29064735
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S, Costich JF, Bunn TL, Luu H, Singleton M, Hargrove SL, Triplett JS, Quesinberry D, Ralston W, Ingram V.
    Int J Drug Policy; 2017 Aug 06; 46():120-129. PubMed ID: 28735777
    [Abstract] [Full Text] [Related]

  • 6. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS, Ponicki W, Smith N, Rivera-Aguirre A, Davis CS, Fink DS, Castillo-Carniglia A, Henry SG, Marshall BDL, Gruenewald P, Cerdá M.
    Int J Drug Policy; 2019 Dec 06; 74():174-180. PubMed ID: 31627159
    [Abstract] [Full Text] [Related]

  • 7. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L, Sanapati J, Benyamin RM, Atluri S, Kaye AD, Hirsch JA.
    Pain Physician; 2018 Jul 06; 21(4):309-326. PubMed ID: 30045589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ, Ellis MS.
    JAMA Psychiatry; 2015 May 06; 72(5):424-30. PubMed ID: 25760692
    [Abstract] [Full Text] [Related]

  • 14. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.
    Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC.
    Annu Rev Public Health; 2015 Mar 18; 36():559-74. PubMed ID: 25581144
    [Abstract] [Full Text] [Related]

  • 15. Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.
    Pouget ER, Fong C, Rosenblum A.
    Subst Use Misuse; 2018 Jan 28; 53(2):290-300. PubMed ID: 28854060
    [Abstract] [Full Text] [Related]

  • 16. The Effects of Kentucky's Comprehensive Opioid Legislation on Patients Presenting with Prescription Opioid or Heroin Abuse to One Urban Emergency Department.
    Faryar KA, Freeman CL, Persaud AK, Furmanek SP, Guinn BE, Mattingly WA, Wiemken TL, Buckner KA, Huecker MR.
    J Emerg Med; 2017 Dec 28; 53(6):805-814. PubMed ID: 29102093
    [Abstract] [Full Text] [Related]

  • 17. Systematic Literature Review of Prescription Drug Monitoring Programs.
    Ponnapalli A, Grando A, Murcko A, Wertheim P.
    AMIA Annu Symp Proc; 2018 Dec 28; 2018():1478-1487. PubMed ID: 30815193
    [Abstract] [Full Text] [Related]

  • 18. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.
    Peacock A, Degenhardt L, Larance B, Cama E, Lintzeris N, Ali R, Bruno R.
    Pharmacoepidemiol Drug Saf; 2015 Dec 28; 24(12):1321-33. PubMed ID: 26419615
    [Abstract] [Full Text] [Related]

  • 19. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
    Shearer RD, Jones A, Howell BA, Segel JE, Winkelman TNA.
    J Subst Abuse Treat; 2022 Dec 28; 143():108894. PubMed ID: 36206585
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity in Prescription Opioid Pain Reliever Misuse Across Age Groups: 2015-2017 National Survey on Drug Use and Health.
    Schuler MS, Dick AW, Stein BD.
    J Gen Intern Med; 2020 Mar 28; 35(3):792-799. PubMed ID: 31792871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.